Brachytherapy
Volume 5, Issue 1 , Page 8 , January 2006

Rebuttal to Dr. Stock

References 

  1. Grills IS, Martinez AA, Hollander M, et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol. 2004;171:1098–1104
  2. Stock RG, Stone NN, Dahlal M, et al. What is the optimal dose for 125I prostate implants? A dose–response analysis of biochemical control, posttreatment prostate biopsies, and long term urinary symptoms. Brachytherapy. 2002;1:83–89
  3. Mate TP, Gottesman JE, Hatton J, et al. High-dose-rate afterloading 192 Iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys. 1998;41:525–533

PII: S1538-4721(06)00004-3

doi: 10.1016/j.brachy.2006.01.002

Brachytherapy
Volume 5, Issue 1 , Page 8 , January 2006

Article Tools